BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 28643167)

  • 1. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
    Westfall S; Lomis N; Kahouli I; Dia SY; Singh SP; Prakash S
    Cell Mol Life Sci; 2017 Oct; 74(20):3769-3787. PubMed ID: 28643167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics.
    Peterson CT
    J Evid Based Integr Med; 2020; 25():2515690X20957225. PubMed ID: 33092396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights.
    Taghizadeh Ghassab F; Shamlou Mahmoudi F; Taheri Tinjani R; Emami Meibodi A; Zali MR; Yadegar A
    Life Sci; 2024 Aug; 350():122748. PubMed ID: 38843992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases.
    Loh JS; Mak WQ; Tan LKS; Ng CX; Chan HH; Yeow SH; Foo JB; Ong YS; How CW; Khaw KY
    Signal Transduct Target Ther; 2024 Feb; 9(1):37. PubMed ID: 38360862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
    Raj K; Singh S; Chib S; Mallan S
    Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders.
    Raval U; Harary JM; Zeng E; Pasinetti GM
    Expert Rev Neurother; 2020 Jul; 20(7):673-686. PubMed ID: 32459513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid system influences gut-brain axis: Dysbiosis and related alterations.
    Rueda-Ruzafa L; Cruz F; Cardona D; Hone AJ; Molina-Torres G; Sánchez-Labraca N; Roman P
    Pharmacol Res; 2020 Sep; 159():104928. PubMed ID: 32504837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review.
    Yadav H; Jaldhi ; Bhardwaj R; Anamika ; Bakshi A; Gupta S; Maurya SK
    Life Sci; 2023 Oct; 330():122022. PubMed ID: 37579835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review.
    Mincic AM; Antal M; Filip L; Miere D
    Clin Nutr; 2024 Jul; 43(7):1832-1849. PubMed ID: 38878554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in understanding the role of the gut microbiota in brain health and disease.
    Sherwin E; Dinan TG; Cryan JF
    Ann N Y Acad Sci; 2018 May; 1420(1):5-25. PubMed ID: 28768369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
    Chen Y; Xu J; Chen Y
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Microbes Affect Depression: Underlying Mechanisms via the Gut-Brain Axis and the Modulating Role of Probiotics.
    Suda K; Matsuda K
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders.
    Marć MA; Jastrząb R; Mytych J
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.